Press Releases
Stay up to date with press releases covering announcements, company news, product launches, and business updates.
Publish your press release
Vera Therapeutics Provides Business Update and Reports Third Quarter 2026 Financial Results
GlobeNewswire, Inc.
TRUTAKNA® (atacicept-vymj) U.S. launch building early momentum following July 7 accelerated approval by the U.S. Food and Drug Administration (FDA) with approximately 700 Patient Start Forms (PSFs) to date and $10.3 million of net product revenue...
DCP Food Sampling of Ground Cinnamon Initiates Multistate Recall Due to Elevated Lead Levels
Connecticut State Department of Consumer Protection
HARTFORD — The Department of Consumer Protection Food and Standards Team collected samples of Wise Wife Brand Ground Cinnamon, resulting in a multistate recall due to elevated lead levels that may be unsafe to consume.
Apyx Medical Corporation Reports Third Quarter 2026 Financial Results
GlobeNewswire, Inc.
Reported total revenue of $14.0 million in the third quarter of 2026 driven by 17% growth in the Surgical Aesthetics segment Initiated successful full commercial launch of the power liposuction handpiece for the AYON system in the third quarter...
Ingredion Incorporated Reports Third Quarter 2026 Results
GlobeNewswire, Inc.
T&HS delivered its 10th consecutive quarter of net sales volume growth, with share gains in strategic categories, including continued clean label growth globally Third quarter 2026 reported and adjusted* operating income both decreased 19%...
The Low-Density Polyethylene Extrusion Market Is Projected to Grow at a 6.7% CAGR Through 2030
EIN Presswire
The Business Research Company's Low-Density Polyethylene Extrusion Market Report 2026 – Market Size, Trends, And Global Forecast 2026-2035 LONDON, GREATER LONDON, UNITED KINGDOM, November 17, 2026 /EINPresswire.com/ -- "The low-density...
President’s Choice® Unveils the 2026 PC® Holiday Insiders Report™
GlobeNewswire, Inc.
BRAMPTON, Ontario, Nov. 05, 2026 (GLOBE NEWSWIRE) -- Today, President’s Choice® unveils the 2026 PC® Holiday Insiders Report™, inviting Canadians to shake up their season.
Mobile Beacon Now Accepting Applications for Connect for Success Connectivity Grants for Schools, with Two Years of Unlimited Service in Every Award
GlobeNewswire, Inc.
Lincoln, RI, Nov. 05, 2026 (GLOBE NEWSWIRE) -- Mobile Beacon, a leading nonprofit provider of connectivity to mission-driven organizations, has launched its Connect for Success Fall/Winter Connectivity Grants for individual classrooms and schools....
Sana Biotechnology Reports Third Quarter 2026 Financial Results and Business Updates
GlobeNewswire, Inc.
Continued progress toward starting SC451 Phase 1/2 trial in type 1 diabetes Continued progress toward starting clinical study for SG293 in non-Hodgkin lymphoma Announced follow-on publication in The New England Journal of Medicine (NEJM)...
TerrAscend Reports Third Quarter 2026 Financial Results
GlobeNewswire, Inc.
Q3 2026 Net Revenue of $68.2 Million, Up 4.8% Year-Over-Year Q3 2026 Gross Profit Margin of 52.3%, Up 20 Basis Points Year-Over-Year Q3 2026 Net Cash Provided from Continuing Operations of $8.8 Million, Representing 17.7% Operating Cash Flow...
Karat Packaging Reports Third Quarter 2026 Financial Results
GlobeNewswire, Inc.
CHINO, Calif., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Karat Packaging Inc. (Nasdaq: KRT) ("Karat Packaging" or the "Company"), a specialty distributor and manufacturer of environmentally friendly, disposable foodservice products and related items,...
BioAge Labs Reports Third Quarter 2026 Financial Results and Provides Business Updates
GlobeNewswire, Inc.
First participant dosed in QUELL-DME, a Phase 2 trial of BGE-102, a potential best-in-class oral NLRP3 inhibitor, in diabetic macular edema; topline results anticipated in the second half of 2027 QUELL-CV, a Phase 2 dose-ranging trial of BGE-102...
Profound Medical Reports Strong Third Quarter 2026 Results; Expands U.S. Distribution and Positions Leadership for Next Phase of Growth
GlobeNewswire, Inc.
Gross margin reaches 78%; cash used in operating activities declines 56% sequentially Profound expects full-year 2026 revenue to be at least $25.0 million; minimum gross margin projection for the year remains at 70% or higher New Cook Medical...
BranchOut Food Reaches Record October Production, Equating to an Approximately $30 Million Annualized Revenue Run Rate and Surpassing Estimated Breakeven
GlobeNewswire, Inc.
BEND, Ore., Nov. 05, 2026 (GLOBE NEWSWIRE) -- BranchOut Food Inc. (Nasdaq: BOF) ("BranchOut" or the "Company"), a food technology company producing fruit, vegetable, and dairy-based snacks and ingredients through its REV dehydration technology,...
vTv Therapeutics Reports Third Quarter 2026 Financial Results and Provides Corporate Update
GlobeNewswire, Inc.
Phase 3 CATT1 trial evaluating cadisegliatin for the treatment of type 1 diabetes (T1D) completed enrollment with 166 participants randomized; topline results expected mid 2027 Randomized the first participant in its Phase 2a Hybrid CATT1 pilot...
Omada Health Reports Third Quarter 2026 Results
GlobeNewswire, Inc.
Quarterly Revenue of $91 million and All-Time High Total Members of 1.1 million Revenue Grew 34% and Total Members Increased 36% Year over Year Raises Full Year 2026 Financial Outlook SAN FRANCISCO, Nov. 05, 2026 (GLOBE NEWSWIRE) -- Omada Health,...
Rezolute Reports First Quarter Fiscal 2027 Financial Results and Provides Business Update
GlobeNewswire, Inc.
REDWOOD CITY, Calif., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT) (Rezolute or the Company), a late-stage ultra-rare, metabolic disease company focused on treating refractory hypoglycemia caused by any form of hyperinsulinism...
Celldex Reports Third Quarter Financial Results and Provides Corporate Update
GlobeNewswire, Inc.
Best-in-disease results from Phase 3 EMBARQ-CSU1 and EMBARQ-CSU2 studies showed rapid, profound, sustained efficacy supporting barzolvolimab’s potential to be a transformational therapy in CSU BLA submission for barzolvolimab in CSU anticipated in...
Corvus Pharmaceuticals Provides Business Update and Reports Third Quarter 2026 Financial Results
GlobeNewswire, Inc.
Enrollment in soquelitinib registrational Phase 3 relapsed/refractory peripheral T-cell lymphoma (PTCL) and Phase 2 atopic dermatitis trials on track Angel Pharmaceuticals completes enrollment in cohort 1 of Phase 1b/2 atopic dermatitis trial;...
LB Pharmaceuticals Reports Third Quarter 2026 Financial Results and Provides Corporate Update
GlobeNewswire, Inc.
Strengthened leadership with the appointment of Susan G. Kozauer, M.D., as Chief Medical Officer and Joseph Miller as Chief Financial Officer On track for topline data readout from the pivotal Phase 3 NOVA-2 trial of LB-102 in schizophrenia in 1H...
ARS Pharma Reports Business Highlights and Third Quarter 2026 Financial Results
GlobeNewswire, Inc.
Total Q3 revenue of $37.7 million, including $33.4 million in U.S. net product revenue for neffy® neffy U.S. market share reached 5% overall and 9% in field-targeted accounts, supporting the company’s updated targeted provider commercial strategy...
Sign up for:
Food & Beverage Report
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.